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Abstract
The mechanism by which hematopoietic stem and progenitor cells (HSPCs) through interaction with their niches maintain
and reconstitute adult hematopoietic cells is unknown. To functionally and genetically track localization of HSPCs with their
niches, we employed novel mutant loxPs, lox66 and lox71 and Cre-recombinase technology to conditionally delete c-Kit in
adult mice, while simultaneously enabling GFP expression in the c-Kit-deficient cells. Conditional deletion of c-Kit resulted in
hematopoietic failure and splenic atrophy both at steady state and after marrow ablation leading to the demise of the
treated adult mice. Within the marrow, the c-Kit-expressing GFP
+ cells were positioned to Kit ligand (KL)-expressing niche
cells. This c-Kit-mediated cellular adhesion was essential for long-term maintenance and expansion of HSPCs. These results
lay the foundation for delivering KL within specific niches to maintain and restore hematopoiesis.
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Introduction
The molecular pathways involved in HSPC-niche cell interac-
tions that maintain hematopoiesis during adulthood and promotes
reconstitution after bone marrow (BM) suppression are not fully
defined. Certain stem cell active factors are important for
embryonic hematopoiesis. However, conditional deletions of these
factors in adult mice do not manifest any major impairment in the
HSPC maintenance, although they may serve essential functions
for hematopoietic recovery after marrow suppression [1,2,3].
KL is expressed by BM niches raising the possibility that c-Kit/
KL signaling might play a critical role in the modulation of steady
state hematopoiesis [4]. In this regard, naturally-occurring W/c-
Kit mutant mice have served as a great model for study of
hematopoietic cell development [5]. Indeed, the encoding protein,
c-Kit receptor tyrosine kinase (RTK) is employed in combination
with other cell surface molecules, such as lineage
2 (Lin
2) and Sca-
1
+ as Lin
2Sca1
+c-Kit
+ (LSK) cells, to identify enriched-population
of hematopoietic stem cells [6,7]. Nonetheless, due to the late
embryonic and early neonatal lethality by the germline c-Kit
deficiency [5], it remains to be determined whether c-Kit is
essential for the maintenance and function of HSPCs in adult
hematopoiesis. To address this question by genetic approach, we
aimed to generate c-Kit conditional knock out (KO) mice to
interrogate the role of c-Kit in hematopoietic function in adult
mice. Moreover, to unravel the mechanism by which c-Kit
regulates interaction of HSPCs with BM microenvironments, we
develop a strategy to locate the position of the c-Kit-expressing
HSPCs within the BM after conditional c-Kit deletion. To achieve
these two goals, we employed mutant loxPs, lox66 and lox71 [8,9]
to create a c-Kit conditional KO GFP-reporter mouse, in which
deletion of c-Kit in cells results in the expression of GFP driven by
the c-Kit native promoter. This approach allowed us to track the
location of the c-Kit-deficient HSPCs within various BM niches
and assess their fate at steady state conditions and during
hematopoietic recovery from BM suppression.
Here, we demonstrate that c-Kit is required for hematopoiesis in
the BM and spleen and the in vivo maintenance and regeneration of
HSPCs in adult mice. Moreover, we identify that c-Kit is essential
for mediating the interactions of HSPCs with niche cells in vitro and
functional positioning of the regenerating HSPCs with
KL
+VEGFR3
+ marrow sinusoidal endothelial cells (SECs) in vivo.
Results
Generation of c-Kit conditional KO GFP-reporter mice
We generated a targeting cassette containing genes, a splice
acceptor (SA) site followed by IRES-GFP-polyadenylations that
were flanked by lox66 and lox71 in head-to-head orientation
(Fig. 1A). The cassette was inserted in anti-sense orientation into
the intron 8 of the c-Kit up-stream from the exon 10, which
encodes the transmembrane domain of c-Kit RTK. The targeted
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26918c-Kit lox66-71 allele will transcribe a full-length c-Kit transcript,
since the inserted genes remain silenced due to the anti-sense
orientation relative to the c-Kit gene. Upon activation of Cre
recombinase, the inserted genes will be flipped, but not excised, by
recombination of lox66 and lox71 [8,9,10]. Therefore, activation of
the c-Kit promoter leads to a splicing event with the inserted SA
initiating the IRES-dependent expression of GFP, while the
polyadenylation signals will silence the downstream genes, which
encode the transmembrane and kinase domains of the c-Kit RTK
resulting in the loss of c-Kit cell surface expression.
To generate c-Kit conditional KO GFP-reporter mice, the
mutant W allele, which codes for a defective molecule lacking the
transmembrane domain of c-Kit thereby resulting in no cell
surface expression of the molecule [11], was introduced by
breeding W heterozygotes (c-Kit
+/W mice) to the germline-
transmitted c-Kit
+/lox66–71 mice (Fig. 1B–C). The introduction of
Figure 1. Generation of c-Kit conditional KO GFP-reporter mice by employing lox66–71 recombination, enabling tracking of c-Kit-
deficient cells. (A) A targeting vector was designed for the insertion of a complex cassette into the 59-region of the c-Kit gene. Lox66 and lox71 sites
in a head-to-head orientation flank splice acceptor (SA): an inserted internal ribosomal entry site (IRES):eGfp as well as two polyadenylation/stop
signals. Prior to Cre recombination, the c-Kit lox66–71 allele will transcribe a full-length c-Kit transcript. Upon activation of Cre, the inserted genes are
inverted by the flanking lox66 and lox71. The IRES downstream from the c-Kit exon 8 allows for a bicistronic expression of eGfp and for an activation
of stop signals from two polyadenylations, thereby creating a transcription stop of the downstream c-Kit gene. B, BamHI; H, HindIII; K, KpnI; RV, EcoRV;
S, SalI; Sb, SbfI; TK, thymidine kinase; X, XbaI. (B) Representative Southern blot screen for ES cells and neo-excised ES clones. XbaI digestion and 39-
flanking probe were used to identify targeted ES cells. The genomic DNAs from the ES clones were digested with BglII, and the blot was probed with
the 39-flanking probe. Expected size of fragments is indicated to the left. Genotypes are indicated above each lane. (C) Schematic strategy to generate
c-Kit conditional KO GFP-reporter mice. (D) Representative FACS dot plot showing the lack of c-Kit expression on Lin
2cells from BM cells of c-Kit
W/DGFP
mice was confirmed by flow cytometric analysis. Left panels show the absence of c-Kit expression on Lin
2 cells isolated from BMs of c-Kit
W/DGFP mice.
Green dots in the Sca-1 and c-Kit profiles gated on Lin
2 cells represent Lin
2Sca-1
+c-Kit::GFP
+ cells. Right panels show that after tamoxifen injections
GFP expression is initiated in heterozygous c-Kit
+/DGFP and c-Kit-deficient c-Kit
W/DGFP mice. Data are representative of more than three experiments
with three mice per genotype.
doi:10.1371/journal.pone.0026918.g001
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required for circumvention of mosaic alleles which could be
produced from Cre-mediated recombinations of the mutant loxPs
between the different alleles. The W heterozygotes hemizygously
carried the ROSA-CreERT2 transgene (c-Kit
+/W; ROSA-
CreERT2
+/Tg mice), allowing recombination of lox66 and lox71
sites upon tamoxifen treatment [12]. To account for any possible
off-targeted phenotypes and Cre toxicity, all mice used for the
following studies hemizygously carried the ROSA-CreERT2
transgene in control c-Kit
+/+, heterozygous c-Kit
+/DGFP, heterozy-
gous c-Kit
+/W, and c-Kit-deficient c-Kit
W/DGFP mice (Fig. 1C, Fig.
S1A). All of the control CreERT2 c-Kit
+/+, CreERT2 c-Kit
+/ lox66–71,
CreERT2 c-Kit
+/W, and CreERT2 c-Kit
W/lox66–71 mice were
treated with equivalent doses of tamoxifen, which resulted in the
generation of control CreERT2 c-Kit
+/+, CreERT2 c-Kit
+/DGFP,
CreERT2 c-Kit
+/W (controls), and c-Kit-deficient CreERT2 c-Kit
W/
DGFP mice (Fig. 1C). After day 10 of tamoxifen injection, c-Kit null
phenotype on Lin
2Sca-1
+ cells was confirmed by flow cytometric
analysis in the BM of c-Kit
W/DGFP mice (Fig. 1C–D). Furthermore,
c-Kit::GFP was expressed in both c-Kit-deficient c-Kit
W/DGFP and
heterozygous c-Kit
+/DGFP mice, after tamoxifen treatment of c-Kit
W/
lox66-71 and c-Kit
+/lox66-71 mice, respectively (Fig. 1D). The c-Kit
expression level on LSK cells from the heterozygous c-Kit
+/DGFP
mice was reduced proportionally to that from c-Kit
+/W hetero-
zygoutes (Fig. 1D), while all of the pre-treated mice, c-Kit
+/+,c - Kit
+/
lox66–71,c - Kit
+/W, and c-Kit
W/lox66–71 mice showed normal c-Kit cell
surface expression (Fig. S1). These data strongly support the notion
that the targeting strategy illustrated in Fig. 1A is efficient to delete
the c-Kit gene and to switch on GFP expression driven by the c-Kit
native promoter.
Adult c-Kit deficiency alters hematopoiesis
The majority of mice in the series of naturally-occurring W/c-
Kit mutants have macrocytic anemia [5]. Therefore, we measured
complete blood counts (CBC) of the c-Kit-deficient c-Kit
W/DGFP
mice to investigate the effect of c-Kit deficiency on blood cell
productions at steady state conditions. Although prior to
tamoxifen treatment all of the CBC were normal, white and red
blood cell counts as well as hemoglobin and hematocrit values in
peripheral blood in the c-Kit-deficient c-Kit
W/DGFP mice were
significantly lower in number in comparison to those in control
mice (Fig. 2A). Notably, platelet counts were normal in the c-Kit-
deficient c-Kit
W/DGFP mice (Fig. 2A). Furthermore, BMs of c-Kit-
deficient c-Kit
W/DGFP mice were hypocellular with disruption of
the normal architecture (Fig. 2B-C), and there was a profound
decrease in the spleen size and reduced number of splenocytes
compared to those in controls (Fig. 2D–E). These data suggest that
c-Kit is required for the maintenance of the steady state
hematopoiesis and spleen mass in adult mice.
Figure 2. Conditional targeting of c-Kit in adult mice results in hematopoietic failures at steady state conditions. (A) c-Kit deficiency
leads to impaired hematopoiesis under steady state conditions. CBC were tested in peripheral blood from each c-Kit-deficient and control mice. Data
are means 6 s.d. (n=3). WBC, white blood cell; RBC, red blood cell: Hb, hemoglobin; Hct, hematocrit; PLT, platelet. (B) Abnormal structure of BMs.
Representative images showing sections of femurs from the control and c-Kit-deficient c-Kit
W/DGFP mice were stained with hematoxylin and eosin
(H&E). Scale bar, 100 mm. (C) Decreased number of BMMNCs in femurs of control and c-Kit-deficient c-Kit
W/DGFP mice after tamoxifen injections. Data
are means 6 s.d. (n=3). (D) Representative image showing reduced size and progressive atrophy of spleens in c-Kit-deficient c-Kit
W/DGFP mice. (E)
Decreased number of splenocytes in c-Kit-deficient c-Kit
W/DGFP mice. Data are means 6 s.d. (n=3).
doi:10.1371/journal.pone.0026918.g002
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stem and progenitor cells
Next, we investigated whether the homeostasis of the pheno-
typically marked primitive hematopoietic cells was altered by c-Kit
deficiency at the steady state conditions. Since the total cellularity
of BM cells of c-Kit-deficient c-Kit
WD/GFP mice was reduced in
number and the c-Kit signaling is known to regulate apoptotic
pathway in some cell types [13,14,15], we examined apoptotic
status of c-Kit-deficient Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells. Flow
cytometric analysis revealed that no apoptotic cells were detected
in LSK and Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells from the BM of
control and c-Kit-deficient c-Kit
W/GFP mice, respectively (Fig. S2).
The number of the stem cell subsets as measured by the
proportions of the CD34
2 Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ and
Thy1.1
lowLin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells in the BM of c-Kit-
deficient c-Kit
W/DGFP mice were significantly decreased as
compared to control mice (Fig. 3A) due to the reduction of BM
cellularity in the c-Kit-deficient c-Kit
W/DGFP mice (Fig. 2C)
although the frequencies of these cell subsets in the BM were
comparable between the control and c-Kit-deficient c-Kit
W/DGFP
mice (data not shown). Moreover, the total number of colony-
forming cells in the BM of c-Kit-deficient c-Kit
W/DGFP mice was
significantly decreased as compared to controls (Fig. 3B), suggest-
ing that at steady state conditions, c-Kit is essential for the
maintenance of phenotypically marked HSPCs.
To assess the hematopoietic reconstitution potential of c-Kit-
deficient HSPCs, we performed competitive reconstitution assays
using immunodeficient NOD/SCID mice lacking CD3
+ T cells.
LSK cells isolated from BM mononuclear cells (BMMNCs) of c-
Kit
+/+ mice, Lin
2Sca-1
+c-Kit
dimc-Kit::GFP
+ purified from
BMMNCs of heterozygous c-Kit
+/DGFP mice or c-Kit-deficient
Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells isolated from BMMNCs of c-
Kit-deficient c-Kit
W/DGFP mice, were transplanted with BMMNCs
from naı ¨ve NOD/SCID mice into irradiated-recipient NOD/
SCID mice (Fig. 3C). Quantification CBC in the recipient mice on
day 34 after transplantation revealed that the numbers of white
blood cells and lymphocytes were increased in peripheral blood of
the recipient mice transplanted with either LSK or Lin
2Sca-1
+c-
Kit
dimc-Kit::GFP
+ cells (Fig. 3D). This suggests that the trans-
planted HSPCs engrafted in the BM of the recipient mice and
gave rise to lymphocyte cell subsets, which lacked in NOD/SCID
mice. However, those numbers in the recipient mice transplanted
with c-Kit-deficient Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells were not
increased compared to controls (Fig. 3D). Additionally, the flow
cytometric analyses revealed that CD3
+ T cells were reconstituted
in the recipient NOD/SCID mice transplanted with LSK or
Lin
2Sca-1
+c-Kit
dimc-Kit::GFP
+ cells, while no CD3
+ T cells were
detected in the recipient NOD/SCID mice transplanted with c-
Kit-deficient Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells (Fig. 3E). Nota-
bly, c-Kit::GFP
+ cells were reconstituted in the BM of the recipient
NOD/SCID mice transplanted with Lin
2Sca-1
+c-Kit
dimc-
Kit::GFP
+ HSPCs, but not in NOD/SCID recipients transplanted
with c-Kit-deficient Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ HSPCs
(Fig. 3E). These results indicate that c-Kit-deficient LSK cells fail
to reconstitute hematopoiesis in the irradiated recipient mice,
suggesting that c-Kit activation is essential for hematopoietic
reconstitution.
c-Kit mediates interaction of HSPCs with niche cells
Cellular adhesion of HSPCs with prototypical BM niche cells,
such as endothelial and stromal cells could play a major role in
maintenance of hematopoiesis. Therefore, we employed in vitro
adhesion and migration assays to determine whether c-Kit
activation is essential for proper interaction of the HSPCs with
the niche cells. To this end, lineage-depleted hematopoietic cells
(Lin
2 cells) isolated from c-Kit-deficient c-Kit
W/DGFP and control
mice were used for Boyden chamber assay and adhesion assay to
laminin, an extracellular matrix component that is deposited by
niche cells. Lin
2 cells derived from c-Kit-deficient c-Kit
W/DGFP
mice manifested severe defects in migration and adhesion as
compared to Lin
2 cells derived from c-Kit
+/+ mice (Fig. 4A). These
data indicate that c-Kit is required for migration and adhesion of
HSPCs to niche cells.
To define the mechanism by which c-Kit deficiency results in
the impairment of hematopoiesis, we interrogated the role of c-Kit
in mediating interaction of HSPCs with BM niche cells
[4,16,17,18,19,20,21]. Specifically, we hypothesized that c-Kit
might regulate adhesion and/or migration of HSPCs to BM
endothelial and stromal cells. To test this hypothesis, we
determined the effect of c-Kit deficiency on adhesion and
migration activities of HSPCs using c-Kit-deficient cells purified
from BMs of c-Kit
W/DGFP mice, in a coculture system with niche
cells [22]. Exogenous sKL stimulated adhesion of Lin
2 cells
derived from the control mice onto both primary endothelial cells
(ECs) and BM-derived stromal cells, cocultured in serum- and
cytokine-free condition. The cocultured hematopoietic cells
formed typical cobblestone colonies on endothelial and stromal
cells, while c-Kit-deficient Lin
2 cells from BMs of c-Kit
W/DGFP
mice detached from endothelial and stromal cells and failed to
form adherent or migrating colonies (Fig. 4B). In addition, some
cells were observed to tightly adhere to ECs and transmigrated
underneath the ECs. The ratio of c-Kit-deficient Lin
2Sca-1
+c-
Kit
2c-Kit::GFP
+ HSPCs that interact with niche cells were much
lower than those of wild-type LSK HSPCs (Fig. 4C). These data
suggest that c-Kit signaling stimulates tight interactions of HSPCs
with niche cells [21,23].
Integrin molecules expressed on cell surface are known to
provide tight adhesion between cells. Unexpectedly, there were no
significant difference in cell surface expressions of a4, a5, a6, and
b1 integrins on between LSK and c-Kit-deficient Lin
2Sca1
+c-
Kit
2c-Kit::GFP
+ cells (Fig. S3). However, as membrane KL
(mKL) supports interaction of mast cells with stromal cells [11,24],
we speculated that mKL expressed on niche cells might also
support interactions of c-Kit-expressing cells to the various spliced
isoforms of KLs expressed on niche cells. After undergoing splicing
KLs generate the membrane isoforms, mKL-1 and mKL-2, which
lacks the metalloproteinase-cleavage site (Fig. S4) [25,26]. Each
KL isoform supported the tight adhesion of wild-type Lin
2
BMMNCs onto ECs (Fig. 4D–E), suggesting that the HSPC-niche
cell interaction is enhanced by the KL-c-Kit signaling. To
investigate whether the c-Kit-mediated interaction was important
for maintenance and expansion of HSPCs, we extended the co-
cultivation period. There was an incremental expansion of LSK
cells purified from BMs of c-Kit
+/+ mice over a 10 day culture
period (Fig. 4F–G). By contrast, c-Kit-deficient Lin
2Sca-1
+c-
Kit
2c-Kit::GFP
+ cells failed to form colonies or proliferate in co-
culture with endothelial and stromal cells (Fig. 4F–G). In addition,
mKL-1 or mKL-2 expressed on ECs supported expansion of large
numbers of LSK cells (Fig. 4H–I). These findings indicate that the
KL-c-Kit interaction accelerates motility and adhesion of HSPCs
to the ECs and stromal cells thereby supporting their long-term
expansion.
c-Kit is essential in regeneration of adult hematopoiesis
To determine whether c-Kit-mediated interaction of HSPCs
with the BM microenvironment is essential for hematopoietic
recovery and conferring HSPCs resistance to BM suppression [16]
in adult mice, we assessed the capacity of the c-Kit conditional KO
c-Kit RTK for Adult Hematopoiesis
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suppression [27]. Although there was a complete recovery of CBC
in the control mice, in the c-Kit-deficient c-Kit
W/DGFP mice there
was a severe impairment in the hematopoietic recovery resulting in
the death of the mice due to persistent pancytopenia by day 14
after 5-FU treatment (Fig. 5A). There was no major obvious organ
Figure 3. c-Kit deficiency impairs reconstitution of HSPCs in the adult mice. (A) c-Kit deficiency decreases hematopoietic stem cell subsets.
Data are means 6 s.d. for the numbers of CD34
2 (left) and Thy1.1
low (right) cells gated on LSK or Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells in the BM of each
genotyped mouse (n=3). (B) c-Kit null affects on hematopoietic progenitor activity. Colony formation was determined with BMMNCs from control
and c-Kit-deficient c-Kit
W/DGFP mice. Data are means 6 s.d. (n=3). (C) Schematic strategy of hematopoietic reconstitution assay. Irradiated T-cell-
deficient NOD/SCID mice were transplanted with LSK cells isolated from c-Kit
+/+ mice, Lin
2Sca-1
+c-Kit
dimc-Kit::GFP
+ cells isolated from heterozygous c-
Kit
+/DGFP mice, or Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells isolated from c-Kit-deficient c-Kit
W/DGFP mice. (D and E) Defective hematopoietic reconstitution by
c-Kit deficiency. The peripheral blood (D) and BM cells (E) from the NOD/SCID recipient mice were analyzed on day 34 after the competitive
transplantation. Percentages represent the fraction of the total gated live cells within the indicated boxes. Data were obtained from or are
representative of three experiments.
doi:10.1371/journal.pone.0026918.g003
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PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26918Figure 4. c-Kit regulates interactions of HSPCs with endothelial and BM stromal cells. (A) Dramatic reduction of migration activity and
adhesion to microenvironment by c-Kit deficiency. Lin
2 BM cells from c-Kit
+/+ and c-Kit-deficient c-Kit
W/DGFP mice were used for migration assay and
assessment of the extent of adhesion to laminin. Data are means 6 s.d. (n=3). (B) c-Kit-deficient Lin
2 BMMNCs fail to form colonies on ECs and
stromal cells. Representative images were obtained from three independent experiments. Magnification, x 40. (C) c-Kit-deficient Lin
2 BMMNCs failed
to adhere onto ECs and stromal cells. Adherent LSK or Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ HSPCs were quantified by flow cytometry. The ratios of adhered
LSK cells from c-Kit
+/+ mice were considered as 1. Data are means 6 s.d. (n=3). (D) KL supports the adhesion and the colony formation of Lin
2
BMMNCs onto ECs. Lin
2 BMMNCs from wild-type mice were transferred onto ECs, which overexpressed mKL-1 or mKL-2. Representative images were
obtained from three independent experiments. Magnification, x 40. (E) KL-c-Kit signaling enhances the adhesion of Lin
2 BMMNCs onto the ECs.
Adherent LSK cells were analyzed by flow cytometry. The ratios of adherent LSK cells onto control ECs were considered as 1. Data are means 6 s.d.
(n=3). (F) c-Kit-deficient Lin
2 BMMNCs fail to produce immature HSPCs on ECs and stromal cells. The co-cultivations were performed as described
above. Representative images were obtained from three experiments. Upper panels, x 4 magnification. Lower panels, x 40 magnification. (G) c-Kit
deficiency fails to produce immature HSPCs. CD45
+, LSK, and c-Kit-deficient Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells were quantified by flow cytometry after
10 days of coculture. Data are means 6 s.d. (n=3). (H) KL supports expansion of LSK cells. Lin
2 BMMNCs from wild-type mice were transferred onto
ECs, which overexpressed either mKL-1 or mKL-2. Representative images were obtained from three experiments. Upper panels, x 4 magnification.
Lower panels, x 40 magnification. (I) KL-c-Kit signaling enhances expansion of LSK cells cocultured with ECs. Adherent LSK cells were analyzed by flow
cytometry. The ratios of adherent LSK cells onto control ECs were considered as 1. Data are means 6 s.d. (n=3).
doi:10.1371/journal.pone.0026918.g004
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not shown). Under BM suppressive conditions, c-Kit-deficient c-
Kit
W/DGFP mice did not reveal the rebound extramedullary
splenomegaly, which was observed in control mice (Fig. 5B). The
spleen size was significantly reduced and atrophied in c-Kit-
deficient c-Kit
W/DGFP mice as compared to even the control
untreated mice. Furthermore, on day 14 after BM suppression, c-
Kit-deficientLin
2Sca-1
+c-Kit
2c-Kit::GFP
+ HSPCs weredecreased
innumber (datanot shown).Notably,inthe BMofc-Kit-deficientc-
Kit
W/DGFPmicetheGFPexpressionwasenhanced comparedtothat
in heterozygous c-Kit
+/DGFP mice on day 14 after the 5-FU injection
(Fig. 5C). These data suggest that c-Kit activation is essential for
hematopoietic reconstitution after BM myeloablation.
c-Kit regulates interactions of HSPCs to KL
+VEGFR3
+
sinusoidal ECs (SECs) in the BM
The advantage of the lox66-lox71 Cre-recombinase conditional
KO GFP-reporter strategy allows us to precisely localize the c-Kit-
deficient c-Kit::GFP
+ cells in the BM during the recovery from
BM suppression. Indeed, c-Kit-deficient c-Kit::GFP
+ cells were
detected in BMs of the 5-FU-treated c-Kit-deficient c-Kit
W/DGFP
mice (Fig. 6). Using VEGFR3 as a marker for SECs in the BM
[27], confocal analysis demonstrated that c-Kit-deficient c-
Kit::GFP
+ cells were close cellular apposition of but detached
from VEGFR3
+ SECs (Fig. 6B). Although at steady state
conditions the expression of mKL was low on VEGFR3
+ SECs
(Fig. 6A), after BM suppression there was a significant upregula-
tion of mKL expression on VEGFR3
+ SECs in the BM (Fig. 6B).
These data suggest that interaction of HSPCs with the SECs
enhanced by KL-c-Kit signaling could be important for hemato-
poietic recovery.
Discussion
We have employed a lox66-lox71 Cre-recombinase conditional
KO approach to dissect c-Kit functions in adult mice. This
strategy not only results in c-Kit deletion but also by genetic
Figure 5. c-Kit-deficient mice fail to reconstitute hematopoietic cells after 5-FU induced marrow depletion. (A) CBC from 5-FU treated
mice were monitored on each time point during hematopoietic recovery from BM depletion. Data are means 6 s.d. (n=3). (B) Lack of c-Kit results in
severe impairment in increase of the spleen size. (C) c-Kit-deficient HSPC-rich population is present in the BM of c-Kit
W/DGFP mice on day 14 after 5-FU
injection. Data were obtained from or are representative of two independent experiments with three mice per genotype.
doi:10.1371/journal.pone.0026918.g005
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these cells for in vitro studies and imaging of the c-Kit-deficient cells
in vivo. We demonstrate for the first time that c-Kit expression is
required for adult hematopoiesis within the BM and spleen at the
steady state conditions and hematopoietic recovery from BM
depletion. Furthermore, we show that c-Kit signaling enhances the
interaction of HSPCs with niche cells, allowing for proper
functional positioning of the repopulating HSPCs within the BM
microenvironment.
Among the known RTKs, expression of Tie2, VEGFR2,
VEGFR1, and FGF-receptors have been implicated in modulating
the homeostasis of HSPCs during the development. However,
none of these RTKs have been shown to play a major role in
mediating the homeostasis of HSPCs in adult mice at steady state
conditions. Therefore, c-Kit is one of the critical RTKs that
modulates the steady state and long-term maintenance of HSPCs.
Here, we demonstrate that both at steady state and after BM
depletion, KL enhances the interaction of c-Kit-expressing cells
with KL
+ niche cells. The mKL-c-Kit pair not only performs as a
survival pathway but also allows for functional positioning of
HSPCs to the various BM niches to maintain HSPCs and
accelerate hematopoietic recovery. Notably, both at steady state
conditions and after 5-FU mediated BM depletion in the c-Kit-
deficient mice there is a profound decrease in the size of spleen,
with a major defect in physiological increase in the spleen size after
BM depletion. It is conceivable that during hematopoietic
recovery the atrophy in the size of spleen might be due to
impaired mobilization of HSPCs from the BM to the spleen.
Alternatively, c-Kit activation may be essential for expansion and
maintenance of HSPCs within the spleen. Mutations of the
juxtamembrane domain tyrosines in c-Kit RTK results in splenic
hypertrophy but in normal hematocrit values in adult mice due to
the loss-of-docking sites for their particular target molecules and
reduced kinase activity [28]. Thus, at steady state conditions,
proper c-Kit signaling is essential to maintain the spleen mass
supporting the homeostasis of HSPCs.
We have taken advantage of lox66-lox71 conditional knock down
of the c-Kit in adult mice, enabling simultaneous tracking of
HSPCs, which lack c-Kit in the BM during the steady state and
after 5-FU hematopoietic suppression. The finding that c-Kit
expression regulates hematopoiesis and spleen size in adult mice
even at the steady state has major clinical implications, setting
Figure 6. c-Kit::GFP
+ cells are positioned in close vicinity to KL
+VEGFR3
+ sinusoidal ECs. Femurs from c-Kit-deficient c-Kit
W/DGFP mice on
day 0 (A) and 14 (B) during BM depletion were co-stained for VEGFR3 (red), which demarcates SECs. Arrows indicate c-Kit-deficient c-Kit::GFP
+ cells.
The dotted lines represent the border between the bone and hematopoietic tissue. The lower image is magnified from the enclosed box. Scale bars,
20 mm.
doi:10.1371/journal.pone.0026918.g006
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in hematopoietic failure states in a wide variety of clinical
disorders.
Materials and Methods
Targeting construct
The fragment containing pGK-HSV-TK was excised from pDEL-
BOY (a gift from D. J. Rossi, Stanford) and inserted between EcoRIa n d
NotI sites of pBluescript II SK (+) (Stratagene, La Jolla, CA). The
plasmid was named A-1_TK-IN. Then a 6.1 KB EcoRV- KpnI
fragment of C57BL/6 genomic DNA containing exons 8–13 of the c-
Kit gene from a bacterial artificial chromosome clone (RP23-142L11)
was ligated with a ClaI linker and subsequently inserted at the sites of
ClaIa n dKpnI of the A-1_TK_IN. The product was named A-2-c-
kit-IN. Two synthesized oligos (59-CCTGCAGGATAACTTCGTA-
TAGCATACATTATACGAACGGTATCCCGGGGGGATGTT
CGGGCGGCCGCCCATAACGGAAGATCTTCCATAACTTC
GTATAATGTATGCTATACGAACGGTATTAATTAACGATG
CCCACATGAGCTCCCTGCAGGTAGCT-93; 39-CATGGGAC
GTCCTATTGAAGCATATCGTATGTAATATGCTTGCCAT-
xAxGGGCCCCCCTACAAGCCCGCCGGCGGGTATTGCCT
TCTAGAAGGTATTGAAGCATATTACATACGATATGCTT
GCCATAATTAATTGCTACGGGTGTACTCGAGGGACGT
CCA-95) containing SbfI, lox66, XmaI, NotI, BglII, lox71, PacI, SacI,
andSbfI siteswereannealedandsubsequentlyintroduced atthesites
of KpnIa n dSacI ofpBluescript IISK (+). Theplasmid was named B-
1_Adapter-IN. A fragment containing an internal ribosomal entry
site (IRES) and eGFP excised from pccall2-IRES-EGFP (a gift from
A. Nagy, Samuel Lunenfeld Research Institute) was subcloned into
the B-1_Adaptor-IN at the BglII and NotI sites. The product was
named B-2_IRES-EGFP-IN. A fragment containing splice acceptor
(SA) from pBS-SA (A1) (a gift from T. Tanaka, UIUC) was
introduced into the sites of BglII and ClaI of the B-2_IRES-EGFP-
IN. The product was named B-2-1_SA-IN. A fragment containing
pGK pA and pGH pA from 2xpA-1 in pGEM-T (a gift from A.
Nagy) was introduced into the sites of NotI and XmaI of the B-2-
1_SA-IN. The product was named B-3-1_2xpA-IN. A SacI-PvuI
fragment containing a neomycin resistance gene (Neo) flanked by Frt
from the pDELBOY was subcloned at the SacIa n dPacI sites of the
B-3-1_2xpA-IN. The product was named B-4-1_Frt-PGK-Neo-IN.
TheSbfI-SbfI fragment containingFrt-flanking theNeoand lox66-71-
flanking the SA, IRES, EGFP, and two pA genes, was excised from
the B-4-1_Frt-PGK-Neo-IN and was inserted at the SbfI site of the
A-2_c-kit-IN.Thefinalproduct is a targetingconstruct,namedA-3-
1-B4-IN.
Mice
The targeting vector was linearized by AhdI and then transfected
byelectroporationinto C2JEScellsderived fromC57BL/6-Tyr
c-2J/
J mice. Colonies doubly resistant for G418 and gancyclovir were
screened by Southern blot analysis for homologous recombination
with XbaI digestion using 39-flanking probe. Subsequently, the Neo
was excised from the targeted allele in the homologous recombinant
ES clones by transient expression of Flippase-puromycin plasmid.
After screening of Neo-excised ES clones by Southern blot
hybridization with BglII digestion using 39-flanking probe, the
screened ES clones were used for microinjections with C57BL/6
blastocysts. Generated chimeric mice were bred with C57BL/6-
Tyr
c-2J/J female mice, and their albino-looking offspring were
genotyped to confirm germline transmission of the c-Kit lox66–71
allele. The ROSA-CreERT2 mice (CD1 back ground) were
obtained from T. N. Sato at Weill Cornell Medical College
(WCMC), NY. C57BL/6-Tyr
c-2J/J, NOD/SCID, and C57BL/
6-background c-Kit
+/W mice were purchased from Jackson
Laboratory (Bar Harbor, ME).
c-Kit conditional KO GFP-reporter mice
For generation of c-Kit
W/lox66-71 mice, the c-Kit
+/lox66-71 mice
were crossed with heterozygous c-Kit
+/W mice carrying hemizy-
gous ROSA CreERT2 transgene. The mice hemizygously
carrying the ROSA CreERT2 transgene were treated with
tamoxifen at a dose of 450 mg/Kg body i.p. for three days. The
treated mice on day 10–14 post tamoxifen were used for the
experiments. All mice were maintained in specific pathogen-free
conditions in the Animal Facility of WCMC. All experiments were
approved by the Institutional Animal Care and Use of Committee
of WCMC (protocol #: 2009-0061).
Genotyping
For the detection of the c-Kit lox66–71 allele, mice were genotyped
using Primer a and Primer b (Primer a, 59-CCC GGA GCC CAC
AAT AGA TTG-93; Primer b, 59- A A CC A GC T GG G GC T CG A A
ATT-93). For genotyping of the c-Kit GFP allele, mice were genotyped
using Primer a and Primer c (Primer c, 59-CGG GCC CTC ACA
TTG CCA AAA-93). For genotyping of the c-Kit wild-type allele, mice
were genotyped using Primer a and Primer d (Primer d, 59-CTG
TCC TGG GAA ATT GCT TTA-93). PCR reactions contained 1 x
PCR buffer containing 1.5 mM MgCl2 (Denville Scientific, South
P l a i n f i e l d ,N J ) ,2 0 0mM deoxynucleotides (Invitrogen, Carlsbad, CA),
0.5 mM primers, and 1 U of Taq DNA polymerase (Denville
Scientific). Cycling conditions were as follows: 94uCf o r5m i n u t e s ,3 5
cycles of 94uC for 1 minute/62uCf o r1m i n u t e / 7 2 uCf o r2m i n u t e s .
Presence of the c-Kit lox66–71 and GFP alleles resulted in a 406 bp
band and a 644 bp band, respectively. The c-Kit wild-type allele was
detected by a 362 bp band. For detection of the cre transgene, mice
were genotyped using primers, Cre S01 and Cre A01 (Cre S01, 59-
CCAAAATTTGCCTGCATTACCGGTCGATGC-93; Cre A01,
59-AGCGCCGTAAATCAATCGATGAGTTGCTTC-93). Reac-
tion conditions were as described above. Cycling conditions were
94uCf o r5m i n u t e s ,3 5c y c l e so f9 4 uC for 30 seconds/58uC for 30
seconds/72uC for 2 minutes, followed by 72uCf o r1 0m i n u t e s .
Isolation of cells and flow cytometry
BMMNCs were obtained from either flushing or crushing
femurs, tibiae, and humerus. They were suspended in MOPS
buffer (Miltenyi Biotech, Inc., Bergisch Gladbach, Germany) and
filtered through nylon screen (45 mm, Sefer America, Kansas City,
MO) to obtain a single cell suspension. Cells were counted using a
hemocytometer. Alive non-stained cells with the DNA-intercalat-
ing dye 4,6-diamidine-2-phenylindole (DAPI, Sigma, St. Louis,
MO) were analyzed by LSRII-SORP equipped with 355-nm, 405-
nm, 488-nm, and 633-nm lasers and FACSDiva 6.1 software (BD
Bioscience, San Jose, CA). All antibodies were purchased from
either BD Bioscience or eBioscience (San Diego, CA). BD; biotin
mouse lineage panel (CD3e (145-2C11), CD11b (M1/70), B220
(RA3-6B2), Gr-1 (RB6-8C5), and TER-119 (TER-119)), c-Kit
(2B8), Sca-1 (D7), CD45.2 (104), rat IgG2a (R35-95), rat IgG2b
(A95-1), Thy1.1 (OX-7), CD34 (RAM34), a4 (R1-2), CD16/
CD32 (2.4G2), CD3e(145-2C11), CD19 (1D3), CD11b (M1/70),
and AnnexinV. eBioscience; a5 (HMa5-1), a6 (GoH3), b1
(HMb1-1), and Armenian hamster IgG (eBio299Arm). Lineage-
depleted cells were prepared using Lineage Cell Depletion Kit
Mouse (Miltenyi Biotech). For purification of cell subsets, the
lineage-depleted cells were used for sorting with FACS Aria flow
sorter (BD).
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Retro-orbital peripheral blood was collected into microhemat-
ocrit capillary tubes (Fisher Scientific, Pittsburgh, PA). CBC were
counted by Bayer Advia 120 Multi-species Hematology Analyzer
with multispecies software (Bayer HealthCare, Tarrytown, NY).
Competitive reconstitution
Sub-lethally irradiated (350 Rads) NOD/SCID mice were
competitively reconstituted with 3610
3 purified LSK, Lin
2Sca-1
+c-
Kit
dimc-Kit::GFP
+,o rL i n
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells from line-
age-depleted BMMNCs from c-Kit
+/+, heterozygous c-Kit
+/DGFP,o rc -
Kit-deficient c-Kit
W/DGFP mice, respectively, in competition with
2610
5 BMMNCs from naı ¨ve NOD/SCID mice. CBC and
BMMNCs from recipient mice were analyzed on day 34 after the
transplantation.
Methylcellulose culture
The colony forming was assayed using MethoCult M3434
(Stem Cell Technologies, Vancouver, Canada).
Organ histology and immunofluorescence
All organs were fixed in 4% paraformaldehyde (PFA). Femurs
were decalcified in 10% EDTA in PBS containing Ca and Mg and
then transferred into either 30% ethanol for preparation of
paraffin sections or 30% sucrose for preparation of frozen sections.
The treated tissues were embedded in OCT medium and frozen in
liquid nitrogen. Hematoxylin and eosin (H&E) stains were done by
Histoserv (Germantown, MD). For IF, the frozen sections (10 mm)
were blocked with 10% normal donkey serum/0.05% Tween 20
in PBS containing Ca and Mg for 2 hr at RT followed by primary
antibody reactions for over night at 4uC. On the next day, the
stained sections were reacted with proper secondary antibodies for
1 hr at RT and then stained with DAPI (Invitrogen) for 20 min at
RT for nuclei counter staining. Fluorescent images were obtained
using Carl Zeiss LSM710 system (Carl Zeiss, Thornwood, NY).
The primary and fluorophore-conjugated secondary antibodies
(Abs) were anti-KL (Santa Cruz, Santa Cruz, CA), anti-VEGFR3
(mF4-31c1, a gift from ImClone Systems, New York, NY), anti-
GFP conjugated with biotin (Invitrogen), and fluorophore-
conjugated Abs (Jackson ImmunoResearch Laboratories, West
Grove, PA).
Migration assay
1610
5 lineage-depleted BMMNCs in 100 mL 0.1% BSA IMDM
(Invitrogen) were placed in the top compartments and 600 mL
medium containing 50 ng/mL mouse recombinant SDF-1a (Pepro
Tech Inc., Rocky Hill, NJ) in the bottom chambers of the 5.0 mm
transwell plates (Corning, Corning, NY). After 6 hr at 37uCi na5 %
CO2 incubator, the migrated cells in the bottom chambers were
harvested and then measured in number using Cell Titer-Glo
Luminescent Cell Viability Assay (Promega, Madison, WI).
Cells and lentivirus infection
ECs and BM-derived stromal cells were prepared as described
[29]. ECs were infected with lentivirus. Lentivirus vector (pCCL-
pGK-GFP-WPRE, a gift from S. Rivella, WCMC) was subcloned
with cDNA of mKL-1 or mKL-2 which were cloned from wild-
type C57BL/6 splenocytes using primers as described [25]. The
RNAs were extracted the infected ECs using RNeasy Mini Kit
(Qiagen Science, Valencia, CA), and cDNAs were synthesized
with SuperScript reverse transcriptase (Invitrogen). qPCR (Taq-
man) was done as described [30]. Primers, mKitL-F, 59-
TGCGGGAATCCTGTGACTGATAATG-93; mKitL-R, 59-
CAAAACATCCATCCCGGCGAC-93.
Adhesion and expansion assays
For adhesion and expansion assays of HSPCs to ECs and BM
stromal cells, 2.5610
5 Lin
2 BMMNCs were placed onto either ECs
or BM-derived stromal cells in non-serum X-VIVO 20 medium
(Lonza, Walkersville, MD) with or without 20 ng/mL mouse
recombinant KL (Pepro Tech Inc.) in 12-well plates. After 18 hr or
10 day culture, adhered cells were harvested by mild treatment of
trypsin and then counted in cell numbers. The number of LSK or c-
Kit-deficient Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells werecalculated by
frequencies of these cells quantified with a flow cytometry LSRII
and the counts of BMMNCs withhemocytometer. In-put LSKor c-
Kit-deficient Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells were also calcu-
lated by the same way, and the % adhesion was determined by the
number of the adhered cells/the number of the in-put cells. For
adhesion assay to laminin, 1610
5 Lin
2 BMMNCs in 100 mL 0.1%
BSA IMDM containing 10 ng/mL mouse recombinant KL were
placed in laminin-coated wells of 96-well plates (BD Bioscience).
After1hrincubationat37uCina 5%CO2incubator,non-adherent
cells were washed out two times by PBS. The adherent cells were
quantified in number using Cell Titer-Glo Luminescent Cell
Viability Assay. The % adhesion was calculated by the number of
adherent cells/in-put cell numbers.
BM suppressive treatment
Mice were injected with 5-FU (250 mg/Kg body weight, Sicor
Pharmaceutical Inc., Irvine, CA) intravenously [27].
Supporting Information
Figure S1 Normal LSK cells in c-Kit conditional KO
GFP-reporter mice in pre-activation of Cre recombi-
nase. (A) Normal LSK cells are present in the BM of c-Kit
W/lox66-71
mice at the time of pre-treatment with tamoxifen. The schema shows
breeding strategy to generate c-Kit
W/lox66–71 mice carrying ROSA-
CreERT2 transgene as well as control ROSA-CreERT2 c-Kit
+/+,
ROSA-CreERT2 c-Kit
+/lox66–71, and ROSA-CreERT2 c-Kit
+/W mice.
The flow cytometric analysis demonstrated that normal population of
LSK cells manifests no GFP expression in the BM of ROSA-CreERT2
c-Kit
+/+,R O S A - C r e E R T 2c - Kit
+/lox66–71,R O S A - C r e E R T 2c - Kit
+/W,
and ROSA-CreERT2 c-Kit
W/lox66–71 mice. The flow cytometric data
are representative of each genotype. (B) Normal number of BMMNCs
in femurs of ROSA-CreERT2 c-Kit
+/+,R O S A - C r e E R T 2c - Kit
+/lox66–71,
ROSA-CreERT2 c-Kit
+/W,a n dR O S A - C r e E R T 2c - Kit
W/lox66–71 mice at
the time of pre-treatment with tamoxifen. Data are means 6 s.d. (n=3).
(TIF)
Figure S2 No apoptosis was detected in c-Kit-deficient
Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells in the BM of c-
Kit
W/DGFP mice. Apoptotic status was examined in LSK or
Lin
2Sca-1
+c-Kit
2c-Kit::GFP
+ cells in the BM of c-Kit
+/+, hetero-
zygous c-Kit
+/DGFP, heterozygous c-Kit
+/W mice, and c-Kit-deficient
c-Kit
W/DGFP mice by staining with AnnexinV. As a positive control,
wild-type mice were irradiated with 950 Rads, and BM cells from
the mice on day 3 post radiation were analyzed for apoptotic status.
Results are mean percentages 6 s.d. of AnnexinV
+ cells gated on
DAPI
2 cells derived from three mice.
(TIF)
Figure S3 Normal expressions of integrins on HSPCs
lacking c-Kit expression. The flow cytometric data show
expressions of a4, a5, a6, and b1 integrins on LSK or Lin
2Sca-
1
+c-Kit
2c-Kit::GFP
+ cells in the BM of c-Kit
+/+, heterozygous c-
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+/DGFP, heterozygous c-Kit
+/W, and c-Kit-deficient c-Kit
W/DGFP
mice. Data are representative of more than three experiments with
three mouse per genotype.
(TIF)
Figure S4 Overexpression of KLs on ECs. (A) Illustrations
show diagrammatic structures of series of KLs and a backbone of
the lentivirus vectors. An asterisk indicates the position of the
proteolytic cleavage site. mKL-1, membrane KL type 1; mKL-2,
membrane KL type 2. Dotted lines indicate the locations of
sequences missing relative to mKL-1. (B) Relative messages of
KLs. ECs were infected with lentivirus carrying mKL-1 or mKL-
2. Messages of the KLs were quantified by qPCR. The value of the
message in ECs was considered as 1.
(TIF)
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